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Abstract
Background: Determining sample sizes for metabolomic experiments is
important but due to the complexity of these experiments, there are cur-
rently no standard methods for sample size estimation in metabolomics.
Since pilot studies are rarely done in metabolomics, currently existing sam-
ple size estimation approaches which rely on pilot data can not be applied.
Results: In this article, an analysis based approach called MetSizeR is
developed to estimate sample size for metabolomic experiments even when
experimental pilot data are not available. The key motivation for MetSizeR
is that it considers the type of analysis the researcher intends to use for data
analysis when estimating sample size. MetSizeR uses information about
the data analysis technique and prior expert knowledge of the metabolomic
experiment to simulate pilot data from a statistical model. Permutation
based techniques are then applied to the simulated pilot data to estimate
the required sample size.
Conclusions: The MetSizeR methodology, and a publicly available soft-
ware package which implements the approach, are illustrated through real
metabolomic applications. Sample size estimates, informed by the intended
statistical analysis technique, and the associated uncertainty are provided.
∗claire.gormley@ucd.ie
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1 Background
In many metabolomic experiments, one of the most important objectives is to dis-
cover the set of metabolites that plays a significant role in distinguishing samples
from two different groups or populations and thus, in the identification of novel
biomarkers Berk et al. (2011). As in any experiment, designing the experiment
is critical if reliable statistically significant metabolites are to be obtained. Since
metabolomic experiments are expensive, it is crucial to determine the optimal
sample size nˆ to attain the desired power to identify discriminating metabolites
without wasting resources or unnecessarily sampling many subjects. However,
metabolomic data are typically high dimensional and correlated meaning sample
size estimation using classical statistical methods is not straight forward.
Currently, in the metabolomics literature, there is no standard method for the
determination of sample size when designing a metabolomic experiment. Several
methods currently exist in the literature for sample size selection in the high-
dimensional data setting Muller et al. (2004); Tibshirani (2006); Liu and Hwanga
(2007); Lin et al. (2010). However, none of these methods are suitable for metabolomic
experiments since many either assume variables have equal variance or are indepen-
dent. More importantly, these methods rely on the existence of some experimental
pilot data on which the actual sample size selection is then based, and are not
based on the method to be used to analyze the data. In metabolomic studies,
experimental pilot data are rarely available, making such sample size selection
approaches redundant.
In this article, we propose a method known as MetSizeR for sample size es-
timation for metabolomic experiments that addresses some of these limitations.
MetSizeR is founded on the idea that the method for selecting sample size firmly
depends on the type of data analysis the researcher intends to employ. In a situa-
tion where experimental pilot data are not available, pseudo-metabolomic data are
simulated from a statistical model. The specific statistical model from which the
pseudo-metabolomic data are simulated depends on the type of statistical analysis
that the metabolomic scientist intends to use. In its current form the MetSizeR
approach assumes the user intends to employ one of the following three statistical
analysis techniques on completion of their experiment:
1. Probabilistic Principal Components Analysis (PPCA) Tipping and Bishop
(1999); Nyamundanda et al. (2010).
2. Probabilistic Principal Components and Covariates Analysis (PPCCA) Nyamundanda et al.
(2010).
3. Dynamic Probabilistic Principal Components Analysis (DPPCA) Nyamundanda et al.
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(2012).
Intuitively the MetSizeR method can be naturally extended to include other anal-
ysis approaches, assuming they are based on a statistical model rather than being
non-parametric in nature.
MetSizeR draws on two currently existing methods (see Muller et al. (2004) and
Tibshirani (2006)) for sample size calculation in high-dimensional data settings.
While the approach in Tibshirani (2006) is based on the existence of an experimen-
tal pilot data set, the approach detailed in Muller et al. (2004) simulates pilot data
from a statistical model. Further, while independence in the data is assumed in
Muller et al. (2004), the approach in Tibshirani (2006) uses permutation methods
to account for the correlation in the experimental pilot data. MetSizeR combines
these ideas of prior simulation and permutation based techniques to estimate the
sample size for metabolomic experiments. The main advantage of the developed
approach is its ability to determine sample size without experimental pilot data
and without assuming variable independence.
A graphic user interface (GUI) software called MetSizeR was developed to im-
plement this approach to estimating sample sizes in R R Development Core Team
(2009). Effort was focused on designing the interface of MetSizeR to encourage
its wide use in the metabolomics community regardless of previous knowledge
of R. The software is available through the R statistical software environment
www.r-project.org.
2 Methods
Metabolomic data sets are typically acquired using analytical technologies such as
nuclear magnetic resonance spectroscopy (NMR) Reo (2002) and mass spectrom-
etry (MS) Dettmer et al. (2007). The spectrum resulting from NMR spectroscopy
is usually divided into spectral bins (representing variables) and the signal inten-
sities within the bins are related to the relative abundances of metabolites. MS
is typically used for targeted metabolomics in which a specified list of metabolites
is measured Patti et al. (2012). The following section describes how the number
of samples required for either an NMR or an MS metabolomic experiment can be
determined under the MetSizeR approach.
2.1 Sample size estimation
Let x¯jg be the estimate of the average signal intensity µjg for metabolite j in sam-
ples from the treatment group g which has corresponding sample size ng, where
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g = 1, 2. Often in metabolomics, the goal of discovering a set of metabolites that
discriminates between samples from two treatment groups is achieved by testing
the hypothesis Hoj : µj1 − µj2 = 0, on each metabolite j, where j = 1, . . . , p. The
aim of discovering discriminating metabolites can be framed as a multiple test-
ing problem as there are p hypotheses to be tested and the probability of falsely
declaring a metabolite as significant increases with p. It is therefore important
to estimate sample size while controlling an error rate to improve the power of
the test for identifying significant metabolites. MetSizeR focuses on controlling
the false discovery rate (FDR, Benjamini and Hochberg (1995)). Here, the FDR
is the expected number of metabolites incorrectly deemed to be significantly dif-
ferent between the two treatment groups, as a proportion of the total number of
metabolites declared to be significant.
The test statistic and its distribution
A test statistic widely used to identify discriminating metabolites is a two sample
t-statistic. The t-statistic TS is evaluated for all metabolites, j = 1, . . . , p, under
the assumption that the null hypothesis of no difference µj1 = µj2 is true:
TSj =
(x¯j1 − x¯j2)
Sj + cf
,
where Sj =
{(
1
n1
+
1
n2
)
(n1 − 1)(sj1)
2 + (n2 − 1)(sj2)
2
n1 + n2 − 2
} 1
2
,
where Sj is the estimate of the pooled standard error for metabolite j. The corre-
sponding within treatment variability estimate is s2jg = (ng−1)
−1
∑ng
i=1(x(jg)i−x¯jg)
2
for g = 1, 2 where x(jg)i denotes the signal intensity for metabolite j in sample i
from the treatment group g. A correction factor cf is a small positive value added
to the standard error of each metabolite to prevent some metabolites with signal
intensity near zero from having large test statistic TSj; such a metabolite may
have TSj ≈ 0/0.
The typical assumption about the null distribution (i.e. the distribution under
the null hypotheses) of the test statistic TSj is the t-distribution with n1 + n2− 2
degrees of freedom. However, when the data violate such an assumption, mislead-
ing sample size estimates would result. Hence, as in Tibshirani (2006), MetSizeR
estimates the null distribution of TSj using a permutation technique. This is a
non-parametric method based on the assumption that under the null hypothesis
of no difference, the distribution of the test statistic does not change no matter
how the group labels of the pilot data are permuted. The data generated using
this approach maintains the between subject variability and the amount of noise
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in the data. The null distribution of the test statistic TS is estimated by randomly
permuting the group labels of pilot data and calculating the test statistic for each
metabolite, TSjt, where t = 1, . . . , T permutations.
Analysis based data simulation
Unfortunately, in most cases, experimental pilot data are not readily available in
metabolomics since pilot studies are rarely done. Therefore, MetSizeR uses the
intended statistical analysis model to simulate pilot data. The simulated pilot data
are then used to learn about the null distribution of the relevant test statistic for
estimating sample size. This simulation approach is similar to that in Muller et al.
(2004) in which pilot data are simulated from the marginal model:
p(x) =
∫
p(x|u, θ)dp(u, θ),
where x is the n× p data matrix, u denotes the latent variables, and θ is a vector
of unknown model parameters. Simulating from the marginal model is achieved by
first generating values of the parameters and the latent variables from the prior dis-
tribution p(u, θ), and then simulating the data from the assumed model p(x|u, θ)
given the simulated values of u and θ.
Currently, MetSizeR assumes the metabolomic practitioner will use one of three
different statistical models p(x|u, θ) to analyse the data from their metabolomic
experiment – either the PPCA, PPCCA or DPPCA model. Simulation of the pa-
rameters of these models is based on the model assumptions and on prior expert
knowledge of metabolomic data properties. As PPCA is equivalent to the widely
used Principal Components Analysis (PCA) method, simulating from the PPCA
model is discussed here; details of the simulation of pilot data from the closely
related PPCCA and DPPCA models are provided in the Additional File. Specif-
ically, PPCA is a probabilistic formulation of PCA based on a Gaussian latent
variable model Tipping and Bishop (1999); Nyamundanda et al. (2010). PPCA
models the high dimensional spectrum xTi = (xi1, . . . , xip) of subject i (i = 1, . . . , n
where n = n1+n2) as a linear function of the corresponding low dimensional latent
variable uTi = (ui1, . . . , uiq), where (q ≪ p). The PPCA model can be expressed
as follows
xi = Wui + µ+ ǫi
where W is a p × q loadings matrix, µ is a mean vector and ǫi is multivariate
Gaussian noise for observation i, i.e. p(ǫi) = MVNp( 0 , σ
2I ) where I denotes the
identity matrix. The latent variable ui is also multivariate Gaussian distributed,
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p(ui) = MVNq( 0 , I ). The maximum likelihood estimates of the loadings matrix
W and the latent variable u in the PPCA model are equivalent to the traditional
PCA loadings matrix and principal component scores. For a given sample size n,
pilot data x can be simulated from the PPCA model as follows:
1. Generate parameter values from their prior distributions:
p(ui) = MVNq(0, I) for i = 1, . . . n.
p(wj) = MVNq(µW ,ΣW ) for j = 1, . . . p.
p(σ2) = IG(α1, α2)
2. Given the generated model parameters and latent variables the pilot data x
are then simulated from the PPCA model:
p(xi|ui,W, σ
2) = MVNp(Wui, σ
2I) for i = 1, . . . , n.
Estimating sample size based on pilot data simulated in this way ensures the
estimated sample size is firmly dependent on the type of model being used to
analyse the real experimental metabolomic data. Hence, MetSizeR represents an
analysis based approach to sample size estimation for metabolomic studies. The
specific steps involved in the MetsizeR algorithm are detailed in the next section.
The MetSizeR Algorithm
The MetSizeR procedure for sample size estimation starts with a number ntry of
different sample sizes and a user-specified FDR (denoted by target.fdr). It then
searches for the optimal sample size nˆ by estimating the FDR for each of the ntry
sample sizes. In order to estimate FDR for each sample size, the null distribution
of the test statistics of all metabolites is estimated and then a shift constant is
added to the test statistics of some po metabolites to allow them to be truly sig-
nificant. The null distribution is estimated by calculating the test statistics of the
permuted pilot data. After obtaining the critical values of the null distribution,
the FDR is estimated. The optimal sample size nˆ is then set to be the sample size
with FDR equal to target.fdr.
In summary, the MetSizeR sample size estimation method proceeds as follows:
1. Specify the input parameters which include the desired level of FDR (target.fdr),
the expected proportion m of significant metabolites and the model to be
used when analyzing the observed metabolomic data.
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2. Simulate pilot data of sample size nk from the assumed analysis model, where
k = 1, . . . , ntry. Pilot data simulation from the PPCA model is detailed in
the previous Section; the Additional File details pilot data simulation from
the PPCCA and DPPCA models.
3. Estimate the null distribution for all metabolites by randomly permuting the
group labels of the simulated pilot data and computing the test statistic TSjt
for each metabolite j and each permuted data set t for T permutations.
4. Estimate the FDR for each permuted data set t = 1, . . . , T :
(a) Consider the corresponding p-vector of the test statistics TSt = (TS1t, TS2t, . . . , TSpt)
for all metabolites on permutation t.
(b) Randomly sample po = m×p of the test statistics TSt and add
δ
̺jt(
√
1
n1
+ 1
n2
)
to their intensities. This allows po metabolites to be truly significant.
Here, δ is the effect size, and ̺jt is the true within group standard
deviation estimated by
Sjt√
1
n1
+ 1
n2
.
(c) A cut off point crit is set to be the ptho largest absolute value of the
test statistics TSt. All metabolites with |TSjt| > crit are declared as
significant. The FDR for permutation t can then be calculated.
5. Estimate the FDR for data simulation s by taking the 50th percentile of the
FDR values of 1, . . . , T permutations.
6. Repeat steps 2 to 5 for s = 1, . . . , SIM simulations and report the 10th, 50th
and 90th percentiles of the FDR values for sample size nk.
7. Repeat steps 2 to 6 for k = 1, . . . , ntry different sample sizes and select the
optimal sample size nˆ as the nk with FDR = target.fdr.
The total number of permutations T used to estimate the sampling distribution
of the test statistics TS was chosen to be twenty. In the samr R package Tibshirani
(2006) 20 permutations were used to estimate the null distribution and they give
accurate estimates of the FDR. Here, the value of the effect size δ is chosen based
on the variance of the underlying model. The optimal sample size nˆ is estimated
by predicting the sample size at target.fdr using a simple linear regression model
on values of FDR above and below the target.fdr with their corresponding sample
sizes nk. The estimated sample size by MetSizeR ensures that the power or the
confidence level in statistical tests reaches (1-target.fdr).
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Parameter Specification: details and guidelines.
The MetSizeR algorithm requires the specification of several parameters; some are
parameters relevant to the intended analysis model, and some are parameters rel-
evant to the sample size estimation procedure itself.
In terms of the MetSizeR GUI which has been developed, the user is requested
to specify parameters specific to the sample size estimation procedure i.e. the num-
ber of bins in the NMR or MS spectrum, the expected proportion of significant
bins, the target FDR and the minimum sample size they wish to be considered.
The default settings of these parameters are 200 spectral bins, 20% significantly
different bins, a target FDR of 5% and a minimum sample size of 4. The choice
of the number and proportion of significantly different spectral bins will naturally
be informed by the metabolomic practitioner’s knowledge, as will the minimum
sample size choice. For the target FDR, again this depends on the conservatism
of the metabolomic practitioner and/or the research question of interest, but a
FDR of 5% is indicative of typical statistical practice. The user can easily re-run
the MetSizeR algorithm for different settings of these parameters to ascertain the
influence of their particular specifications. However, within the MetSizeR GUI the
user has the option of requesting plots of the expected proportion of significant
bins versus the FDR, over different sample sizes, giving insight to the influence of
this particularly influential parameter on sample size estimation. Regarding the
specification of parameters relevant to the intended analysis model, in the Met-
SizeR GUI, the user is only required to specify the intended analysis model (PPCA,
PPCCA or DPPCA), and in the case of PPCCA, the number of covariates to be
included. Both of these decisions are again practitioner informed, depending on
the particular experiment under consideration. The MetSizeR manual, available
through the developed MetSizeR GUI, guides the user through these parameter
specification steps using a number of illustrative examples.
The remaining parameters in the MetSizeR algorithm have been fixed within
the R code underlying the MetSizeR GUI, but given the open source nature of
R, these can be changed by the user if desired. In the context of the PPCA
model discussed above the hyperparameters of the prior distributions of the load-
ings matrix W and the variance σ2 are based on previous estimates of W and σ2
from applications of PPCA to metabolomic data (eg. Nyamundanda et al. (2010,
2012)). Each row of the loadings matrixW is simulated from a standard multivari-
ate Gaussian distribution MVNq(0, I) and the noise variance σ
2 is simulated from
an inverse gamma distribution with shape parameter α1 = 3 and scale parameter
α2 = 4. Hyperparameter settings for the PPCCA and DPPCA models are detailed
in the Additional File. Within the MetSizeR algorithm four final parameters are
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specified: the effect size δ (fixed at 2.3, the 99th quantile of the assumed prior
distribution of the loadings), the correction factor cf (fixed as the fifth percentile
of the estimated standard errors of all metabolites), the number of permutations
T (set to 20) and the number of simulations SIM (set at 20). These specifica-
tions are based on the choices in Tibshirani (2006); Lin et al. (2010); Hwang et al.
(2002) in similar sample size estimation settings.
3 Results
This section illustrates the application of MetSizeR to different metabolomic ex-
perimental settings. In the first section, MetSizeR is employed to estimate sample
size in the setting where experimental pilot data are not available; the second
section considers the case where experimental pilot data are available.
3.1 Sample size estimation using simulated pilot data
Here the MetSizeR approach to sample size estimation is illustrated in the setting
where experimental pilot data are not available and it is assumed that the user
has indicated that a PPCA model will be used to analyze the observed experimen-
tal data. Further, it is assumed that the user has specified that the spectra will
consist of 300 spectral bins, the target FDR is 5% and the expected proportion of
significant spectral bins is 20%. In this example, the user has also specified that
they wish to consider a minimum sample size of ten, with five in each treatment
group (i.e. n1 = 5 and n2 = 5). All other MetSizeR parameters are set at their
default values, as detailed in the previous section. The MetSizeR method was then
applied, and the 10th, 50th and 90th percentiles of the FDR were calculated across
a range of sample sizes and are shown in Figure 1. The sample size at which the
target FDR of 5% was achieved was estimated to be 30 with 15 in each treatment
group as shown in Figure 1(A).
The expected proportion of significant spectral bins specified by the user im-
pacts on the estimated number of samples required for the metabolomic experi-
ment. Figures 1(B), 1(C) and 1(D) demonstrate the effect on FDR of varying the
expected proportion of significant spectral bins for three different sample sizes.
The figures show that, increasing the expected proportion of significant spectral
bins reduces the FDR.
A second example which demonstrates the applicability of MetSizeR is based
on an experimental paradigm where additional information is available in the form
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Figure 1: In each panel is the estimated FDR (solid red lines) as well as the 10th
and 90th percentiles (dashed red lines). A horizontal dashed black line is the target
FDR at 5%. (A) The sample size nˆ is estimated to be 30 with 15 samples in each
treatment group. (B-D) show the effect of varying the proportion of significant
bins over a range of sample sizes.
of covariates. In this instance, the PPCCA model will be used to analyze the ac-
quired data and thus was used to simulate pilot data with 300 spectral bins, five
samples from each treatment group and two covariates. Fixing the target FDR
at 5% and the expected proportion at 20%, Figure 2(A) demonstrates that when
two covariates are included in the PPCCA model, the total number of samples
required for such an experiment increases to 36 with 18 samples in each treatment
group.
Figure 2(B) illustrates a third example of the setting where no experimen-
tal pilot data are available and the practitioner aims to conduct a longitudinal
metabolomic experiment. The pilot data for this example are simulated from the
DPPCA model; the data are simulated by only focusing on the first time point of
the experiment as it is expected that the same number of subjects will be followed
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over time and that, while there may be dropouts, the largest number of subjects
will be present at the first time point. Figure 2(B) shows that the expected number
of samples required for a longitudinal study of 300 spectral bins with 20% signif-
icant bins and a target FDR of 5%, is 24 with 12 samples from each treatment
group.
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Figure 2: (A) The estimated sample size using the PPCCA model with two covari-
ates. (B) The estimated sample size for a longitudinal study using the DPPCA
model.
3.2 Sample size estimation with experimental pilot data
In a situation where experimental pilot data are available, parameter estimates
used for simulations are based on fitting the underlying model to the experimental
pilot data. Here, the application of MetSizeR is illustrated using real metabolomic
data sets as experimental pilot data.
The first experimental pilot data set is from a longitudinal metabolomic animal
study. Urine samples of 18 animals in two treatment groups were collected over
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a 15 day period and the animals’ weights were measured. Details of this study
have been previously detailed in Carmody and Brennan (2010). Data from day 10
of the study were used as experimental pilot data here; the NMR spectra consist
of 189 spectral bins with nine samples in each treatment group. The PPCCA
model was fitted to the experimental pilot data, with weight as a covariate and
the maximum likelihood parameter estimates from fitting this model are used for
data simulations in MetSizeR. Controlling the target FDR at 5% and setting the
expected proportion of significant bins at 20%, the MetSizeR method was em-
ployed. Figure 3(A) depicts that the sample size estimate is 40, with 20 samples
in each treatment group. It is interesting to note that, the 10% and 90% curves in
Figure 3(A) are much narrower than in the previous examples in which MetSizeR
was used to estimate sample size with no experimental pilot data (Figures 1 and
2). This reduction in uncertainty is due to the fact that MetSizeR simulations are
now based on fixed parameter values not on draws from prior distributions as used
when experimental pilot data are not available.
The approach developed here for sample size estimation is not limited to NMR
data. The method has been developed to accept data from targeted metabolomic
analysis using MS, thus ensuring its applicability across the metabolomics com-
munity. Setting MetSizeR specifications as in the previous examples, the PPCA
model was fitted to a targeted metabolomic MS pilot data set and under the
MetSizR algorithm, the estimated sample size is shown in Figure 3(B).
4 Conclusions
Determining sample sizes in metabolomics is important but due to the complex-
ity of these experiments, there are currently no standard methods for sample
size estimation in metabolomics. Moreover, since pilot studies are rarely done
in metabolomics, sample size estimation approaches for high dimensional data
studies requiring experimental pilot data, cannot be applied.
The method presented in this article is a straight forward approach for deter-
mining sample sizes for metabolomic experiments whilst controlling the FDR. The
main advantage of the developed approach is its ability to determine sample size
even when experimental pilot data are not available. Another key advantage is
that it takes the type of analysis the researcher intends to use into consideration
when estimating sample size and this can improve the power of the study. Also,
since MetSizeR employs permutation techniques to estimate sample size, it ac-
counts for correlation between metabolites and effect size variability. The method
has been developed to accept both NMR and targeted MS data which will ensure
12
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Figure 3: (A) The estimated sample size using the PPCCA model on NMR pilot
data with weights of subjects as a covariate. (B) The estimated sample size using
the PPCA model with targeted MS metabolomic pilot data.
wide applicability in the metabolomics community. Further, a software package
facilitates easy implementation of the MetSizeR approach.
Areas of future work are multiple and varied. MetSizeR is currently designed
to estimate the number of samples required for metabolomic experiments which
involve two groups; modifications to the MetSizeR approach are possible to accom-
modate different metabolomic experimental designs. Alternatives to the permu-
tation approach employed in MetSizeR could be examined – bootstrap sampling
would provide an interesting alternative. Proof of concept metabolomic experi-
ments are currently underway to validate the MetSizeR approach.
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